Evaluation of circulating protein biomarkers for cancer detection using Illumina Protein Prep platform
ASHG CoLab
Details
Join us to hear Krishna Morampudi, Associate Director of Product Management at Illumina, provide an overview of the Illumina Protein Prep product and workflow. Dr. Kamel Lahouel, PhD at TGen will also present on a new pilot study using the Illumina Protein Prep assay to investigate the potential of circulating protein concentrations as biomarkers for cancer detection.
Krishna Morampudi Associate Director of Product Management
Illumina
Kamel Lahouel, PhD Assistant Professor
The Translational Genomics Research Institute
M-AMR-01685
Fill Out Form to Access Webinar
Your email address is never shared with third parties.
APHL 2025 is a conference for the public health laboratory community, bringing together leaders, scientists, influencers and partners to share issues, trends, and best practices driving laboratory science and public health today.